<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03091790</url>
  </required_header>
  <id_info>
    <org_study_id>HSC-MS-16-0936</org_study_id>
    <nct_id>NCT03091790</nct_id>
  </id_info>
  <brief_title>Mesh Type in Ventral Hernia Repair</brief_title>
  <official_title>Mesh Type in Ventral Hernia Repair</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Texas Health Science Center, Houston</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ventral hernias are common following abdominal surgery. Currently, there is no equipoise on
      when synthetic and biologic meshes should be used. Among open ventral hernia repairs, half
      are repaired using biologic mesh while half are repaired using synthetic mesh. The
      investigators hypothesize that biologic mesh as opposed to synthetic mesh repair of open
      ventral hernia repair is associated with decreased risk of major complications one year after
      surgery.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 27, 2017</start_date>
  <completion_date type="Anticipated">March 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Complication free at 1 year post-operative</measure>
    <time_frame>1 year after surgery</time_frame>
    <description>Complication defined as hernia recurrence, chronic wound complications including mesh infection, and reoperation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complication free at 3 years post-operative</measure>
    <time_frame>3 years after surgery</time_frame>
    <description>Complication defined as hernia recurrence, chronic wound complications including mesh infection, and reoperation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dindo-clavien complications</measure>
    <time_frame>Pre-operative, 1 month after surgery, 1 year and 3 years after surgery</time_frame>
    <description>Grade I to V</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient centered outcomes</measure>
    <time_frame>Pre-operative, 1 month after surgery, 1 year and 3 years after surgery</time_frame>
    <description>includes patient satisfaction, cosmetic satisfaction, modified assessment scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost</measure>
    <time_frame>1 year and 3 years after surgery</time_frame>
    <description>charges for all patient visits, admissions, and procedures</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Ventral Hernia</condition>
  <arm_group>
    <arm_group_label>Synthetic Mesh</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Synthetic mesh (mid-density polypropylene (generic) Bard soft mesh) will be used in open ventral hernia repair</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Biologic Mesh</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Biologic mesh (non cross linked porcine acellular dermal matrix: Strattice) will be used in open ventral hernia repair</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Synthetic Mesh</intervention_name>
    <description>Synthetic mesh used during open ventral hernia repair</description>
    <arm_group_label>Synthetic Mesh</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Biologic Mesh</intervention_name>
    <description>Biologic mesh used during open ventral hernia repair</description>
    <arm_group_label>Biologic Mesh</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient scheduled for open ventral hernia repair at LBJ General Hospital

        Exclusion Criteria:

          -  Active infection

          -  Patient unlikely to survive with the next 2 years based upon surgeon judgment (i.e.
             metastatic cancer, end-stage cirrhosis)

          -  Patient surgeon would not normally place a prosthetic (e.g. planned second surgery
             such as ostomy takedown)

          -  Patient unlikely to follow-up (i.e. no phone)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mike Liang, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>UT Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mike Liang, M.D.</last_name>
    <phone>713-566-5095</phone>
    <email>Mike.K.Liang@uth.tmc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Debbie F Lew, M.P.H.</last_name>
    <phone>713-566-5097</phone>
    <email>Debbie.F.Lew@uth.tmc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UT Health at Lyndon B. Johnson General Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77026</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mike K Liang, M.D.</last_name>
      <phone>713-566-5095</phone>
      <email>Mike.K.Liang@uth.tmc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Debbie F Lew, M.P.H.</last_name>
      <phone>713-566-5097</phone>
      <email>Debbie.F.Lew@uth.tmc.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 21, 2017</study_first_submitted>
  <study_first_submitted_qc>March 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 27, 2017</study_first_posted>
  <last_update_submitted>April 30, 2018</last_update_submitted>
  <last_update_submitted_qc>April 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Texas Health Science Center, Houston</investigator_affiliation>
    <investigator_full_name>Mike K Liang</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>ventral hernia</keyword>
  <keyword>mesh</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Hernia, Ventral</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

